|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | The Promise of Immunotherapy in Treating Autoimmune Diseases" |
| Authors Name: | Lucy Mohapatra |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_194472
|
| Published Paper Id: | IJNRD2305185 |
| Published In: | Volume 8 Issue 5, May-2023 |
| DOI: | |
| Abstract: | Immunotherapy, which uses the body's own immune system to fight disease, has shown great promise in treating a variety of autoimmune diseases. In autoimmune diseases, the immune system mistakenly attacks the body's own tissues and organs, leading to chronic inflammation and tissue damage. Conventional treatments for autoimmune diseases such as steroids and immunosuppressants can have significant side effects and may not be effective in all patients. Immunotherapy offers a more targeted approach that can modulate the immune system and restore its normal function. This review article discusses the mechanisms of action of immunotherapy in autoimmune diseases, the status of immunotherapy in clinical practice, and the challenges that need to be addressed to fully realize the promise of immunotherapy in treating autoimmune diseases. While there is still much to be learned, immunotherapy represents a promising avenue for the treatment of autoimmune diseases, offering the potential for more effective and less toxic therapies for patients. |
| Keywords: | Immunotherapy, Autoimmune Diseases, Mechanisms of Action, Clinical Practice, Targeted Approach |
| Cite Article: | "The Promise of Immunotherapy in Treating Autoimmune Diseases"", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 5, page no.b655-b660, May-2023, Available :http://www.ijnrd.org/papers/IJNRD2305185.pdf |
| Downloads: | 000118752 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2305185 Registration ID: 194472 Published In: Volume 8 Issue 5, May-2023 DOI (Digital Object Identifier): Page No: b655-b660 Country: Lucknow, Uttar Pradesh, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2305185 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2305185 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn